Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Japanese POEMS Syndrome with Thalidomide Trial (J-POST extension safety trial)
jRCT2091220084Completed
- Sponsor
- J-POST Clinical Trial Office
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of thalidomide in osteosclerotic myeloma (POEMS), sponsored by J-POST Clinical Trial Office. Primary endpoint: Adverse events associated with FPF 300 (thalidomide). Started Mar 2012; status: completed.
02
Drugs
thalidomide
03
Conditions
osteosclerotic myeloma (POEMS)
Beyond the preview
Go deeper on jRCT2091220084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2091220084.